William J. Caragol, Chairman and CEO of PositiveID, is Featured in a New Audio Interview at SmallCapVoice.com
AUSTIN, Texas, May 1, 2013 /PRNewswire/ -- SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation ("PositiveID" or "Company") (OTCBB: PSIDD), a developer of biological detection and diagnostics solutions, is now available. The interview can be heard at http://smallcapvoice.com/blog/4-30-13-smallcapvoice-interview-with-positiveid-corporation-psidd
William J. Caragol, Chairman and CEO of PositiveID, called into SmallCapVoice.com to discuss the recent milestones achieved by the Company, the launch of the development of the Firefly Dx detection system, the goals for PositiveID in 2013, and much more.
"We believe 2013 holds significant opportunity for PositiveID and we will continue our strategic focus on our biological detection and diagnostics capabilities," stated Caragol. "As we await the release of the final request for proposal from the Department of Homeland Security for Stage 1 of BioWatch Generation 3, expected to be released in 2013, we are also looking ahead to new applications of our patented technology such as our Firefly Dx detection system, a handheld, point-of-need system designed to be used in the identification of biological threats, including biological agents associated with bioterrorism, within minutes."
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
SIGN UP FOR OUR FREE STOCK ALERTS http://www.smallcapvoice.com/newsletter.html
Like us on Facebook http://www.facebook.com/pages/SmallCapVoice/101910803171
Follow us on Twitter https://twitter.com/#!/smallcapvoice
Statements about PositiveID's future expectations, including, without limitation, the likelihood that the Company will launch development of the Firefly Dx detection system; the likelihood that 2013 holds significant opportunity for PositiveID; the likelihood that the release of the final request for proposal from the Department of Homeland Security for Stage 1 of BioWatch Generation 3 will be released by June 30, 2013; the likelihood that there is a new application of the Company's technology such as its Firefly Dx detection system; the likelihood that Firefly can be used in the identification of biological threats, including biological agents associated with bioterrorism, within minutes; and all statements in this press release constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company's ability to participate in BioWatch Generation 3; the Company's ability to target the bio-threat detection and rapid medical testing sectors; the Company's ability to attract the research and development capital to complete the development of Firefly; as well as other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on April 16, 2013 under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Stuart T. Smith